Disappearance of Trisomy +8 In A Case with Myelodysplastic Syndrome After Azacitidine Therapy Followed by Lenalidomide Treatment

Viktoria Varbanova, Raynov J and Lubomir Mitev
Additional contact information
Raynov J: Clinic of Hematology, Military Medical Academy (MMA), Bulgaria
Lubomir Mitev: Department of Cytogenetic and Molecular Biology, Military Medical Academy (MMA), Bulgaria

Biomedical Journal of Scientific & Technical Research, 2019, vol. 23, issue 4, 17555-17557

Abstract: Myelodysplastic Syndrome (MDS) is clonal hematopoietic stem cell disorders with a variety of molecular ...

Keywords: Biomedical Sciences; Biomedical Research; Technical Research; Myelodysplastic Syndrome; 5q- Syndrome; Lenolidomide (search for similar items in EconPapers)
Date: 2019
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://biomedres.us/pdfs/BJSTR.MS.ID.003927.pdf (application/pdf)
https://biomedres.us/fulltexts/BJSTR.MS.ID.003927.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:abf:journl:v:23:y:2019:i:4:p:17555-17557

DOI: 10.26717/BJSTR.2019.23.003927

Access Statistics for this article

Biomedical Journal of Scientific & Technical Research is currently edited by Robert Thomas

More articles in Biomedical Journal of Scientific & Technical Research from Biomedical Research Network+, LLC
Bibliographic data for series maintained by Angela Roy ().